• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳糖衍生的益生元和益生菌共生对胃肠道系统的生物活性。

Biological Activities of Lactose-Derived Prebiotics and Symbiotic with Probiotics on Gastrointestinal System.

机构信息

Department of Food Engineering, Faculty of Food Science, Szent István University, Ménesi st 44, H-1118 Budapest, Hungary.

Soós Ernő Water Technology Research Centre, Faculty of Engineering, University of Pannonia, Zrínyi M. u. 18, H-8800 Nagykanizsa, Hungary.

出版信息

Medicina (Kaunas). 2018 Apr 17;54(2):18. doi: 10.3390/medicina54020018.

DOI:10.3390/medicina54020018
PMID:30344249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6037253/
Abstract

Lactose-derived prebiotics provide wide ranges of gastrointestinal comforts. In this review article, the probable biochemical mechanisms through which lactose-derived prebiotics offer positive gastrointestinal health are reported along with the up-to-date results of clinical investigations; this might be the first review article of its kind, to the best of our knowledge. Lactose-derived prebiotics have unique biological and functional values, and they are confirmed as 'safe' by the Food and Drug Administration federal agency. Medical practitioners frequently recommend them as therapeutics as a pure form or combined with dairy-based products (yoghurt, milk and infant formulas) or fruit juices. The biological activities of lactose-derived prebiotics are expressed in the presence of gut microflora, mainly probiotics ( spp. in the small intestine and spp. in the large intestine). Clinical investigations reveal that galacto-oligosaccharide reduces the risks of several types of diarrhea (traveler's diarrhea, osmotic diarrhea and Clostridium difficile associated relapsing diarrhea). Lactulose and lactosucrose prevent inflammatory bowel diseases (Crohn's disease and ulcerative colitis). Lactulose and lactitol reduce the risk of hepatic encephalopathy. Furthermore, lactulose, galacto-oligosaccharide and lactitol prevent constipation in individuals of all ages. It is expected that the present review article will receive great attention from medical practitioners and food technologists.

摘要

乳糖衍生的益生元提供广泛的胃肠道舒适。在这篇综述文章中,报告了乳糖衍生的益生元提供积极的胃肠道健康的可能生化机制,以及最新的临床研究结果;据我们所知,这可能是此类综述文章中的第一篇。乳糖衍生的益生元具有独特的生物学和功能价值,它们已被食品和药物管理局联邦机构确认为“安全”。医疗从业者经常将它们作为纯形式或与乳制品(酸奶、牛奶和婴儿配方奶粉)或果汁结合推荐作为治疗方法。乳糖衍生的益生元的生物活性在肠道微生物群的存在下表达,主要是益生菌(在小肠中 和 在大肠中)。临床研究表明,半乳糖低聚糖降低了几种类型腹泻(旅行者腹泻、渗透性腹泻和艰难梭菌相关复发性腹泻)的风险。乳果糖和乳蔗糖可预防炎症性肠病(克罗恩病和溃疡性结肠炎)。乳果糖和山梨醇可降低肝性脑病的风险。此外,乳果糖、半乳糖低聚糖和山梨醇可预防各年龄段人群的便秘。预计本综述文章将受到医疗从业者和食品技术人员的高度关注。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2714/6037253/993038b78e1a/medicina-54-00018-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2714/6037253/95957f53b1be/medicina-54-00018-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2714/6037253/fdac18435b5f/medicina-54-00018-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2714/6037253/6eb339c2b48e/medicina-54-00018-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2714/6037253/a7c56e4c6ab9/medicina-54-00018-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2714/6037253/988f6bfef629/medicina-54-00018-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2714/6037253/993038b78e1a/medicina-54-00018-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2714/6037253/95957f53b1be/medicina-54-00018-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2714/6037253/fdac18435b5f/medicina-54-00018-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2714/6037253/6eb339c2b48e/medicina-54-00018-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2714/6037253/a7c56e4c6ab9/medicina-54-00018-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2714/6037253/988f6bfef629/medicina-54-00018-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2714/6037253/993038b78e1a/medicina-54-00018-g006.jpg

相似文献

1
Biological Activities of Lactose-Derived Prebiotics and Symbiotic with Probiotics on Gastrointestinal System.乳糖衍生的益生元和益生菌共生对胃肠道系统的生物活性。
Medicina (Kaunas). 2018 Apr 17;54(2):18. doi: 10.3390/medicina54020018.
2
Biological Activities of Lactose-Based Prebiotics and Symbiosis with Probiotics on Controlling Osteoporosis, Blood-Lipid and Glucose Levels.基于乳糖的益生元的生物活性及其与益生菌的共生作用对控制骨质疏松症、血脂和血糖水平的影响
Medicina (Kaunas). 2018 Dec 3;54(6):98. doi: 10.3390/medicina54060098.
3
Protection from gastrointestinal diseases with the use of probiotics.使用益生菌预防胃肠道疾病。
Am J Clin Nutr. 2001 Feb;73(2 Suppl):430S-436S. doi: 10.1093/ajcn/73.2.430s.
4
Review article: prebiotics in the gastrointestinal tract.综述文章:胃肠道中的益生元
Aliment Pharmacol Ther. 2006 Sep 1;24(5):701-14. doi: 10.1111/j.1365-2036.2006.03042.x.
5
Effects of probiotics and prebiotics on intestinal microbiota in mice with acute colitis based on 16S rRNA gene sequencing.基于 16S rRNA 基因测序的益生菌和益生元对急性结肠炎小鼠肠道微生物群的影响。
Chin Med J (Engl). 2019 Aug 5;132(15):1833-1842. doi: 10.1097/CM9.0000000000000308.
6
Prebiotics as gut microflora management tools.益生元作为肠道微生物群管理工具。
J Clin Gastroenterol. 2008 Jul;42 Suppl 2:S75-9. doi: 10.1097/MCG.0b013e31815ed097.
7
Galactooligosaccharides derived from lactose and lactulose: influence of structure on Lactobacillus, Streptococcus and Bifidobacterium growth.半乳糖寡糖来源于乳糖和乳果糖:结构对乳杆菌、链球菌和双歧杆菌生长的影响。
Int J Food Microbiol. 2011 Sep 1;149(1):81-7. doi: 10.1016/j.ijfoodmicro.2011.05.026. Epub 2011 Jun 12.
8
Prebiotics and probiotics: are they functional foods?益生元和益生菌:它们是功能性食品吗?
Am J Clin Nutr. 2000 Jun;71(6 Suppl):1682S-7S; discussion 1688S-90S. doi: 10.1093/ajcn/71.6.1682S.
9
[Probiotics--an alternative for antibiotics?].[益生菌——抗生素的替代品?]
Wiad Lek. 2004;57(9-10):491-8.
10
The use of probiotics in gastrointestinal disease.益生菌在胃肠道疾病中的应用。
Can J Gastroenterol. 2001 Dec;15(12):817-22. doi: 10.1155/2001/690741.

引用本文的文献

1
Cow's Milk Bioactive Molecules in the Regulation of Glucose Homeostasis in Human and Animal Studies.牛奶生物活性分子在人类和动物研究中对葡萄糖稳态的调节作用
Foods. 2024 Sep 6;13(17):2837. doi: 10.3390/foods13172837.
2
The effects of lactulose on constipation in patients with Parkinson's disease: An exploratory pilot study.乳果糖对帕金森病患者便秘的影响:一项探索性初步研究。
eNeurologicalSci. 2024 May 10;35:100503. doi: 10.1016/j.ensci.2024.100503. eCollection 2024 Jun.
3
Unraveling the Puzzle: Health Benefits of Probiotics-A Comprehensive Review.

本文引用的文献

1
Gut Microbiome-based Therapeutics in Liver Cirrhosis: Basic Consideration for the Next Step.基于肠道微生物群的肝硬化治疗:下一步的基本考量
J Clin Transl Hepatol. 2017 Sep 28;5(3):249-260. doi: 10.14218/JCTH.2017.00008. Epub 2017 Jun 29.
2
Effects of Probiotics, Prebiotics, and Synbiotics on Human Health.益生菌、益生元和合生制剂对人类健康的影响。
Nutrients. 2017 Sep 15;9(9):1021. doi: 10.3390/nu9091021.
3
Antioxidant Properties of Probiotic Bacteria.益生菌的抗氧化特性
解开谜团:益生菌对健康的益处——全面综述
J Clin Med. 2024 Mar 1;13(5):1436. doi: 10.3390/jcm13051436.
4
Delivery Strategies of Probiotics from Nano- and Microparticles: Trends in the Treatment of Inflammatory Bowel Disease-An Overview.纳米和微粒中益生菌的递送策略:炎症性肠病治疗的趋势——综述
Pharmaceutics. 2023 Nov 8;15(11):2600. doi: 10.3390/pharmaceutics15112600.
5
Severe acute hepatitis of unknown etiology in children in 2022: A Narrative Review.2022年儿童病因不明的严重急性肝炎:一篇叙述性综述。
New Microbes New Infect. 2023 Jan 21;51:101087. doi: 10.1016/j.nmni.2023.101087. eCollection 2023 Jan.
6
Clinical Application Value of PS128 in Patients with Anxiety Disorders.PS128在焦虑症患者中的临床应用价值
Clin Psychopharmacol Neurosci. 2022 Aug 31;20(3):560-566. doi: 10.9758/cpn.2022.20.3.560.
7
Prebiotics as a Tool for the Prevention and Treatment of Obesity and Diabetes: Classification and Ability to Modulate the Gut Microbiota.益生元作为预防和治疗肥胖和糖尿病的工具:分类和调节肠道微生物群的能力。
Int J Mol Sci. 2022 May 29;23(11):6097. doi: 10.3390/ijms23116097.
8
Lactulose Modulates the Structure of Gut Microbiota and Alleviates Colitis-Associated Tumorigenesis.乳果糖调节肠道微生物群的结构并缓解结肠炎相关的肿瘤发生。
Nutrients. 2022 Feb 3;14(3):649. doi: 10.3390/nu14030649.
9
Novel Insights Into Pathogenesis and Therapeutic Strategies of Hepatic Encephalopathy, From the Gut Microbiota Perspective.从肠道微生物组角度看肝性脑病的发病机制和治疗策略的新见解。
Front Cell Infect Microbiol. 2021 Feb 22;11:586427. doi: 10.3389/fcimb.2021.586427. eCollection 2021.
10
Plausible Biological Interactions of Low- and Non-Calorie Sweeteners with the Intestinal Microbiota: An Update of Recent Studies.低热量和无热量甜味剂与肠道微生物群的合理生物学相互作用:近期研究的更新。
Nutrients. 2020 Apr 21;12(4):1153. doi: 10.3390/nu12041153.
Nutrients. 2017 May 19;9(5):521. doi: 10.3390/nu9050521.
4
Effects of Prebiotics and Synbiotics on Functional Constipation.益生元与合生元对功能性便秘的影响。
Am J Med Sci. 2017 Mar;353(3):282-292. doi: 10.1016/j.amjms.2016.09.014. Epub 2016 Oct 4.
5
Current targeted therapies in the treatment of advanced colorectal cancer: a review.晚期结直肠癌治疗中的当前靶向疗法:综述
Ther Adv Med Oncol. 2016 Jul;8(4):276-93. doi: 10.1177/1758834016646734. Epub 2016 May 29.
6
Hepatic Encephalopathy: From the Pathogenesis to the New Treatments.肝性脑病:从发病机制到新疗法
ISRN Hepatol. 2014 Jun 4;2014:236268. doi: 10.1155/2014/236268. eCollection 2014.
7
Colorectal cancer carcinogenesis: a review of mechanisms.结直肠癌的致癌作用:机制综述
Cancer Biol Med. 2016 Mar;13(1):120-35. doi: 10.28092/j.issn.2095-3941.2015.0103.
8
Probiotics, prebiotics and colorectal cancer prevention.益生菌、益生元与结直肠癌预防
Best Pract Res Clin Gastroenterol. 2016 Feb;30(1):119-31. doi: 10.1016/j.bpg.2016.02.009. Epub 2016 Feb 19.
9
Induction of regulatory T cells: A role for probiotics and prebiotics to suppress autoimmunity.诱导调节性 T 细胞:益生菌和益生元抑制自身免疫的作用。
Autoimmun Rev. 2016 Apr;15(4):379-92. doi: 10.1016/j.autrev.2016.01.002. Epub 2016 Jan 7.
10
Probiotics, prebiotics and synbiotics- a review.益生菌、益生元与合生元——综述
J Food Sci Technol. 2015 Dec;52(12):7577-87. doi: 10.1007/s13197-015-1921-1. Epub 2015 Jul 22.